Technical Analysis

Technical Analysis
Comprehensive insights into market trends, chart patterns, and key indicators. Equip yourself with the tools and strategies to make data-driven trading decisions.

Biopharma Industry Eyes 2025 Rebound, Navigates Uncertain Policy Landscape Under New Administration

Biopharma Industry Eyes 2025 Rebound, Navigates Uncertain Policy Landscape Under New Administration

Biopharma anticipates a 2025 rebound despite policy uncertainty under the new administration, particularly regarding drug pricing and the Inflation Reduction Act’s impact. Investor focus remains on Medicare negotiations and potential legislative changes, as companies navigate patent expirations and seek new growth opportunities.

Biopharma Industry Eyes 2025 Rebound, Navigates Uncertain Policy Landscape Under New Administration Read More »